Edwards Lifesciences (EW) Return on Capital Employed Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -1,962.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 31.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -846.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,318.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -247.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 362.00 |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 150.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -846.00 |
| Dec 31, 2025 | -930.00 |
| Sep 30, 2025 | -991.00 |
| Jun 30, 2025 | -991.00 |
| Mar 31, 2025 | -1,101.00 |
| Dec 31, 2024 | -1,118.00 |
| Sep 30, 2024 | -928.00 |
| Jun 30, 2024 | -854.00 |
| Mar 31, 2024 | 134.00 |
| Dec 31, 2023 | 204.00 |
| Sep 30, 2023 | 43.00 |
| Jun 30, 2023 | 156.00 |
| Mar 31, 2023 | -264.00 |
| Dec 31, 2022 | -141.00 |
| Sep 30, 2022 | 537.00 |
| Jun 30, 2022 | 603.00 |
| Mar 31, 2022 | 703.00 |
| Dec 31, 2021 | 745.00 |
| Sep 30, 2021 | 12.00 |
| Jun 30, 2021 | 189.00 |
| Mar 31, 2021 | -919.00 |
| Dec 31, 2020 | -1,155.00 |
| Sep 30, 2020 | -599.00 |
| Dec 31, 2019 | 132.00 |
| Dec 31, 2018 | -272.00 |
| Dec 31, 2017 | 983.00 |
| Dec 31, 2016 | -10.00 |
| Dec 31, 2015 | -346.00 |
| Dec 31, 2014 | 523.00 |
| Dec 31, 2013 | 666.00 |